• You could beat the market in the 2020s with these ASX healthcare shares

    healthcare shares

    Over the last five years the healthcare sector has been one of the best performing areas of the share market.

    During this time the S&P/ASX 200 Health Care index has gained more than 125%. This has vastly outperformed the S&P/ASX 200 Index (ASX: XJO) which is only up 7.5% over the same period (excluding dividends).

    While I doubt this level of outperformance will continue over the next five years, I believe the healthcare sector is still very well-placed to beat the market.

    Especially given the increasing demand for healthcare services due to ageing populations, increased chronic disease burden, and product and technological developments.

    In light of this, I think having exposure to the healthcare sector would be a very smart move. Here are two ASX healthcare shares that I would buy:

    CSL Limited (ASX: CSL)

    The first healthcare share to consider buying is CSL. It is one of the world’s leading biotherapeutics companies and has a portfolio of life-saving therapies and vaccines. In addition to this, CSL invests heavily in research and development. This investment means it has a large number of therapies in its pipeline that have the potential to generates significant sales over the next decade. Combined, I believe CSL is well-positioned to continue growing its earnings at a solid rate throughout the 2020s.

    ResMed Inc. (ASX: RMD)

    Another healthcare share to consider buying is ResMed. It was a very strong performer over the 2010s and I feel confident it can repeat this throughout the 2020s. This is due to the medical device company’s focus on the sleep treatment market. The proliferation of obstructive sleep apnoea is driving increasing demand for masks and software solutions. Given the quality of its offering and its wide distribution network, I believe it is well-placed to capture this growing demand and deliver strong earnings growth this decade.

    And named below are more top shares which I think could beat the market over the next decade…

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post You could beat the market in the 2020s with these ASX healthcare shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37BNuzn

  • How to earn $50,000 in dividends each year with ASX shares

    Young female investor holding cash

    When it comes to dividends, many investors will look for shares which offer above-average yields.

    While this is completely fine if you’re in need of an immediate source of income (especially in this low interest rate environment), it may not be the best way to invest in dividend shares.

    If you have time on your side, then I believe you should be looking at shares that pay dividends and have the potential to grow strongly over the next decade and beyond.

    To demonstrate why, I’m going to compare a couple of shares.

    Comparing dividend shares.

    Let’s start with Commonwealth Bank of Australia (ASX: CBA). I think Australia’s largest bank is a great option right now for investors that are looking for immediate income.

    I estimate that its shares offer a forward fully franked yield of approximately 5.2%. However, if you’re not in need of income right now, it may not be the share to buy.

    This is because if we were to jump ahead by 10 years, I don’t believe the yield on offer will be vastly superior to what it is today.

    Next year I suspect the bank will cut its dividend down to approximately $3.70 per share. If it were to then grow this dividend by an average of 5% per annum for the following 10 years, in 2031 Commonwealth Bank would be paying a $6.03 per share dividend.

    This equates to a yield on cost (the yield on the price you paid for the shares) of ~9%. While this is a generous yield, I think we can do better.

    How can we do better?

    One share that I think could be a future dividend star is ecommerce company Kogan.com Ltd (ASX: KGN).

    Next year I expect Kogan to pay a 30 cents per share dividend. This equates to a fully franked 2.3%. While this isn’t anywhere near as good as Commonwealth Bank’s yield, I believe it could overtake it in time.

    Given Kogan’s extremely positive outlook thanks to its increasingly popular website, acquisition plans, and the seismic shift to online shopping, I believe it is well-placed to grow both its earnings and dividends at a strong rate over the next decade.

    My bull case is for Kogan to grow its earnings and dividends by an average of 20% per annum between 2021 and 2031.

    If this proves accurate, then Kogan’s dividend would have grown to 185.7 cents by the end of FY 2031. At that point, if you bought shares today, you would have a yield on cost of approximately 14.1%.

    But why stop there? If we then assume that it can continue growing its dividend by 7.5% per annum for the following 10 years, by FY 2041 its dividend would have grown to approximately 383 cents per share. This represents a yield on cost of 29%.

    This means that $172,000 invested in Kogan’s shares today, could be generating dividends of $50,000 in 2041.

    Foolish Takeaway.

    I believe this demonstrates why some of the best dividend shares could actually be the ones with the lowest yields.

    This could make it well worth considering a long term investment in Kogan and also tech shares such as Altium Limited (ASX: ALU) and Appen Ltd (ASX: APX).

    All three look exceptionally well positioned to deliver long term growth and could increase their dividends materially over the next two decades if all goes to plan.

    And here are more top shares which look like future stars…

    5 ASX stocks under $5

    One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.

    Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post How to earn $50,000 in dividends each year with ASX shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3d49yDS

  • Westpac tips the Australian dollar to continue rising

    Australian and US currency

    The Australian dollar certainly has been in fine form over the last few weeks. And if the economics team at Westpac Banking Corp (ASX: WBC) are to be believed, there could be more gains ahead for the local currency.

    Which could be good news for companies like ARB Corporation Limited (ASX: ARB), Nick Scali Limited (ASX: NCK), and Reject Shop Ltd (ASX: TRS). This is because these companies pay for some of their goods in U.S. dollars, so a stronger local currency gives them more bang for their buck.

    Why does Westpac think the Australian dollar can go higher?

    Westpac’s chief economist, Bill Evans, notes that the Australian dollar has been on fire recently.

    This strong gain has been driven largely by the solid performance of the iron ore price, which is up 25% from a level the bank previously felt was vulnerable to the downside.

    However, given the supply disruption in Brazil and increasing demand in China, Westpac has changed its tune and appears confident that iron ore prices can stay higher for longer.

    Mr Evans said: “We recognise that these positive influences on the iron ore price are unlikely to fade in the foreseeable future. Global opinion is highly sceptical about Brazil’s ability and commitment to bring the virus under control. China seems determined to make up for the “lost” first quarter, particularly in construction, over the course of the remainder of 2020 – and cram twelve months’ activity into nine.”

    In light of this, the bank has lifted its year-end target for the Australian dollar by 4 U.S. cents to 72 U.S. cents.

    What about in 2021?

    Looking ahead, the chief economist expects a global growth recovery to boost demand for Australia’s key exports and support the Australian dollar.

    “We are expecting global growth to lift from minus 3% (some forecasters such as OECD are now forecasting much deeper contractions of up to 6% in 2020) in 2020 to positive 5% in 2021, including a stunning 10% growth momentum in China,” Evans explained.

    The bank expects this to take the Australian dollar up to 76 U.S. cents by the end of 2021.

    Though, Mr Evans notes that there are downside risks to its forecasts, particular if the RBA were to take rates into negative territory.

    The chief economist explained: “Downside outcomes for inflation and growth, exacerbated by an over-valued AUD, may well see the Bank reassessing its caution towards reducing the cash rate below zero.”

    I think the Westpac economics team makes some great points and these forecasts could well prove accurate. This could make it a good time to look at shares that will benefit… and maybe start planning your next overseas holiday.

    5 ASX stocks under $5

    One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.

    Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor James Mickleboro owns shares of Westpac Banking. The Motley Fool Australia has recommended ARB Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Westpac tips the Australian dollar to continue rising appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37q0iZd